Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 2153-2165

  Spittaels, Kurt ^a   Van Den Haute, Chris ^a   Van Dorpe, Jo ^a   Bruynseels, Koen ^a   Vandezande, Kris ^a   Laenen, Isabelle ^a   Geerts, Hugo ^b   Mercken, Marc ^b   Sciot, Raf ^c   Van Lommel, Alfons ^c   Loos, Ruth ^a   Van Leuven, Fred ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CHROMOSOME 17; CONTROLLED STUDY; GENE DOSAGE; GENE MUTATION; GENE OVEREXPRESSION; MOUSE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SPINAL CORD; TRANSGENIC MOUSE;

EID: 0032786370     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65533-2     Document Type: Article

References (68)

1. Wiche G, Oberkanins C, Himmler A: Molecular structure and function of microtubule-associated proteins. Int Rev Cytol 1991, 124:217-273
2. Billingsley ML, Kincaid RL: Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration Biochem J 1997, 323:577-591
3. Mandelkow EM, Mandelkow E: Tau in Alzheimer's disease. Trends Cell Biol 1998, 8:125-127
4. Goedert M, Spillantini MG, Crowther RA: Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci USA 1992, 89:1983-1987
5. Andreadis A, Brown WM, Kosik KS: Structure and novel exons of the human tau gene Biochemistry 1992, 31:10626-10633
6. Boyne LJ, Tessler A, Murray M, Fischer I: Distribution of big tau in the central nervous system of the adult and developing rat. J Comp Neural 1995, 358:279-293
7. Shea TB, Beermann ML, Nixon RA, Fischer I Microtubule-associated protein tau is required for axonal neurite elaboration by neuroblastoma cells. J Neurcsci Res 1992, 32:363-374
8. Knops J, Kosik KS, Lee G, Pardee JD, Cohen-Gould L. McConlogue L: Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol 1991, 144:725-733
9. Esmaeli-Azad B, McCarty JH, Feinstein SC: Sense and antisense translection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J Cell Sci 1994, 107:869-879
10. Brandt R, Léger J, Lee G Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1995, 131:1327-1340
11. Caceres A, Kosik KS: Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 1990, 343: 461-463
12. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N: Altered microtubule organization in small-caliber axons of mice lacking tau protein. Nature 1994, 369:488-491
13. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S. Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M Joosse M, Kwon JM, Nowotny P: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705
14. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741
15. Dumanchin C, Camuzat A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier-Veber P, Martin C, Penet C, Charbonnter F, Agid Y, Frebourg T, Brice A: Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia ana parkinsonism. Hum Mol Genet 1998, 7:1825-1829
16. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998, 43:815-825
17. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM-Y, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC: Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17 Proc Natl Acad Sci USA 1998, 95:13103-13107
18. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P: High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999, 64:414-421
19. Iijima M, Tabira T, Poorkaj P, Schellenberg GD, Trojanowski JQ, Lee VM-Y, Schmidt ML, Takahashi K, Nabika T, Matsumoto T, Yamashita Y, Yoshioka S, Ishino H: A distinct familial dementia with a novel missense mutation in the tau gene. NeuroReport 1999, 10:497-501
20. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JG, Lee MYV: Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998, 282:1914-1917
21. Hasegawa M, Smith MJ, Goedert M: Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998, 437:207-210
22. Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M: FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 1999, 443:93-96
23. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM-Y, Bird TD, Schellenberg GD: Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 1999, 96:5598-5603
24. Götz J, Probst A, Spillantini MG, Schäfer T, Jakes R, Bürki K, Goedert M: Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice overexpressing the longest human brain tau isoform. EMBO J 1995, 14:1304-1313
25. Brion JP, Tremp G, Octave JN: Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 1999, 154:255-270
26. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526
27. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F: Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996, 15:1265-1274
28. Lamberty Y, Gower AJ: Age-related changes in spontaneous behaviour and learning in NMRI mice from middle to old age Phys Behav 1991, 51:81-88
29. Moechars D, Dewachter I, Lorent K. Reversé D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Van den Haute C, Checler F, Godaux E, Cordell B, Van Leuven F: Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999, 274:6483-6492
30. Brion JP, Hanger DP, Bruce MT, Couck A-M, Flament-Durand J, Anderton BH: Tau in Alzheimer neurofibrillary tangles. Biochem J 1991, 273:127-133
31. Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Van de Voorde A, Martin J-J, Gheuens J: Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes Acta Neuropathol 1992, 84:265-272
32. Biernat J, Mandelkow E-M, Schroter C, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E: The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 1992, 11:1593-1597
33. Goedert M, Jakes R, Crowther A, Cohen P, Vanmechelen E, Vandermeeren M, Cras P: Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994, 301:871-877
34. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM-Y: Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673
35. Ksiezak-Reding H, Davies P, Yen S-H: Alz-50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J Biol Chem 1988, 263:7943-7947
36. Carmel G, Mager EM, Binder LI, Kuret J: The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996, 271:32789-32795
37. Jicha GA, Bowser R, Kazam IG, Davies P: Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 1997, 48:128-132
38. Cox G: Neuropathological Techniques: Theory and Practice of Histological Techniques. Edited by JD Bancroft and A Stevens. Edinburgh, London, Churchill Livingstone, 1977, pp 249-273
39. Gibson PH: Ultrastructural abnormalities in the cerebral neocortex and hippocampus associated with Alzheimer's disease and aging. Acta Neuropathol 1987, 73:86-91
40. Spillantini MG, Goedert M: Tau protein pathology in neurodegenerative disease. Trends Neurosci 1998, 21:428-433
41. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow EM, Mandelkow E: Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmatic reticulum: implications for Alzheimer's disease. J Cell Biol 1998, 143:777-794
42. Behar L, Marx R, Sadot E, Barg J, Ginzburg I: cis-acting signals and trans-acting proteins are involved in tau mRNA targeting into neurites of differentiating neuronal cells. Int J Dev Neurosci 1995, 13:113-127
43. Braak E, Braak H. Mandelkow EM: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994, 87:554-567
44. Hall GF, Yao J, Lee G: Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. Proc Natl Acad Sci USA 1997, 94:4733-4738
45. Duff K: Recent work on Alzheimer's disease transgenics Curr Opin Biotechnol 1998, 9:561-564
46. Midroni G, Bilbao JM: Biopsy Diagnosis of Peripheral Neuropathy. Edited by G, Midroni, JM Bilbao. Boston, Butterworth-Heinemann, 1995, pp 45-74
47. Hirano A, Donnenfeld H, Sasaki S, Nakano I: Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984, 34:461-470
48. Côté F, Collard JF, Julien JP: Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotropic lateral sclerosis. Cell 1993, 73:35-46
49. Collard JF, Côté F, Julien JP: Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995, 375:61-64
50. Xu Z, Cork LC, Griffin JW, Cleveland DW: Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993, 73:23-33
51. Lee MK, Marszlek JR, Cleveland DW: A mutant neurotilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994, 13:975-988
52. Su JH, Cummings BJ, Cotman CW: Identification and distribution of axonal dystrophic neuntes in Alzheimer's disease. Brain Res 1993, 625:228-237
53. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME: Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 1998, 21:516-520
54. Bigio EH, Brown DF, White CL. Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 1999, 58: 359-364
55. Goedert M, Spillantini MG, Crowther RA, Chen SG, Parchi P, Tabaton M, Lanska DJ, Markesbery WR, Wilhelmsen KC, Dickson DW, Petersen RB, Gambetti P: Tau gene mutation in familial progressive subcortical gliosis. Nature Med 1999, 5:454-457
56. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B: Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997, 94:4113-4118
57. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AAF, Keohane C, Nygaard TG, Fahn S, Mayeux R, Rowland LP, Wilhelmsen KC: Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994, 44:1878-1884
58. Kampers T, Pangalos M, Geerts H, Wiech H. Mandelkow E: Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett 1999, 451:39-44
59. Hong M, Chen DCR, Klein PS, Lee VMY: Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997, 272:25326-25332
60. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E: MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule distribution. Cell 1997, 89:297-308
61. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K: Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 1992, 267:10897-10901
62. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K: Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 1996, 92:232-241
63. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L: Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996, 40:759-766
64. Good PF, Werner P, Hsu A, Olanow CW, Perl DP: Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996, 149:21-28
65. Dewar D, Graham DI, Teasdale GM, McCulloch J: Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. Acta Neuropathol 1993, 86:623-629
66. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA: Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996, 383:550-553
67. Perry G, Siedlak SL, Richey P, Kawai M, Cras P, Kalaria RN, Galloway PG, Scardina JM, Cordell B, Greenberg BD, Ledbetter SR, Gambetti P: Association of heparan sulphate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci 1991, 11:3679-3683
68. Su JH, Cummings BJ, Cotman CW: Localization of heparan sulphate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 1992, 51:801-813